NOUVAG Receives FDA 510(k) Clearance for LipoSurg ARTIST, the Next Generation of Power-Assisted Liposuction

Newly cleared LipoSurg ARTIST^® integrates infiltration of TLA, power-assisted liposuction and aspiration into one system designed around the modern body contouring workflow.

The next generation of power-assisted liposuction is coming to the U.S.

GOLDACH, CH / ACCESS Newswire / September 8, 2026 / NOUVAG AG today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for LipoSurg ARTIST^®, its new power-assisted liposuction system for aesthetic body contouring.

LipoSurg ARTIST^® brings together infiltration, power-assisted liposuction and aspiration in one integrated system, developed around the surgical workflow and the needs of today's plastic surgeons.

FDA clearance of LipoSurg ARTIST^® marks an important milestone for NOUVAG and the beginning of a new chapter for us in the United States. ARTIST was developed with one clear idea: technology should follow the need of the surgeon, not the other way around. We are excited to finally bring that vision to the U.S. market.

Built on more than 50 years of NOUVAG's experience in powered surgical technology, LipoSurg ARTIST^® represents a new generation of the company's technology for aesthetic surgery.

The ARTIST has arrived.

About NOUVAG

NOUVAG is a Swiss medical technology company developing and manufacturing powered systems and tools for surgical applications since 1971. Its products are used by healthcare professionals worldwide across aesthetic surgery and other surgical specialties.

AG, St Gallerstrasse 25, 9403 Goldach, Switzerland
[email protected]
+41 78 732 17 11

SOURCE: NOUVAG